On patient-centric treatment decisions and the value of quantitative methodologies, in conversation with Marc Buyse

In today's healthcare landscape, there is a pressing need for quantitative methodologies that include the patients' perspective in any treatment decision.
In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Marc Buyse, founder of IDDI and One2Treat, and also co-founder of CluePoints, about his recent work as one of the editors of โ and a chapter contributor to โ the first edition of "๐๐ข๐ฏ๐ฅ๐ฃ๐ฐ๐ฐ๐ฌ ๐ฐ๐ง ๐๐ฆ๐ฏ๐ฆ๐ณ๐ข๐ญ๐ช๐ป๐ฆ๐ฅ ๐๐ข๐ช๐ณ๐ธ๐ช๐ด๐ฆ ๐๐ฐ๐ฎ๐ฑ๐ข๐ณ๐ช๐ด๐ฐ๐ฏ๐ด: ๐๐ฆ๐ต๐ฉ๐ฐ๐ฅ๐ด ๐ง๐ฐ๐ณ ๐๐ข๐ต๐ช๐ฆ๐ฏ๐ต-๐๐ฆ๐ฏ๐ต๐ณ๐ช๐ค ๐๐ฏ๐ข๐ญ๐บ๐ด๐ช๐ด", recently published by the Routledge Taylor & Francis Group.
The conversation explores generalised pairwise comparisons (or GPCs), applications in various disease areas, implications for regulatory approvals and benefit-risk analyses, and considerations for patient centricity in clinical research and treatment decisions.
You can also listen to episode 189a of theโฏpharmaphorum podcastโฏin the player below, download the episode to your computer, or find it - and subscribe to the rest of the series โ on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.